Content from the Brookings-Tsinghua Public Policy Center is now archived. Since October 1, 2020, Brookings has maintained a limited partnership with Tsinghua University School of Public Policy and Management that is intended to facilitate jointly organized dialogues, meetings, and/or events.
As the COVID-19 pandemic continues, spawning new variants around the world, few issues are more pressing than controlling its spread. There is an urgent need for the world’s two largest economies — which have come together on virtually every global health crisis of the 21st century — to join forces again to stop the pandemic. With addressing COVID-19 a top priority for leaders in both Washington and Beijing, it is a critical time for collaboration.
On Monday, March 1, the Brookings Institution and Tsinghua University provided a forum for leading public health and medical experts in both countries to explore the way forward with concrete policy recommendations for medical and research cooperation, vaccine development and distribution, and international protocols for global travel and trade.
Viewers submitted questions via email to email@example.com or join the conversation on Twitter using #USChina.
Director-General - Chinese Center for Disease Control and Prevention
Director - Center for Infection and Immunity, Mailman School of Public Health, Columbia University
Head, Expert Group - National Health Comission
President and CEO - Resolve to Save Lives
Former Director - U.S. Centers for Disease Control and Prevention (CDC)
Lead Director - AmerisourceBergen Corporation
Former Commissioner - U.S. Food and Drug Administration (FDA)
Chief Epidemiologist - Chinese Center for Disease Control and Prevention
Director of the Department of Infectious Disease - Huashan Hospital, Fudan University
To subscribe or manage your subscriptions to our top event topic lists, please visit our event topics page.